{
    "symbol": "THC",
    "quarter": 2,
    "year": 2022,
    "date": "2022-07-22 16:20:18",
    "content": " First, we plan to continue allocating at least $200 million of capital annually to grow our USPI surgery center business; second, to enhance our hospital growth opportunities including the continued focus on higher acuity service offerings; third, evaluate further opportunities to retire debt or refinance debt; and finally, possibly next year and beyond evaluating a share repurchase program depending on market conditions and other investment opportunities. Please proceed with your question. Please proceed with your question. Please proceed with your question. Please proceed with your question. One, the cyber incident is certainly a big part of that, but also when you think about the back half of the year, based on the volume trends that we saw in the first quarter and second quarter as well as how we\u00e2\u0080\u0099ve been managing and our operations and looking at the marginal cost of certain volumes and whether those marginal costs economically makes sense to staff for those volumes. Please proceed with your question. Please proceed with your question. Please proceed with your question. Please proceed with your question. Please proceed with your question. Please proceed with your question. Now the one thing I would say, and that's on the hospital side, the rate update on the USPI side is more attractive, although we still believe it's insufficient given the current inflationary environment and we anticipate that that annual adjustment to the rates based on what's been proposed for USPI, that would be approximately $25 million of additional EBITDA on an annual basis going forward based on the current proposed rule. Please proceed with your question. Please proceed with your question. Please proceed with your question."
}